317 related articles for article (PubMed ID: 19281226)
21. Epidermal growth factor: modulator of murine embryonic palate mesenchymal cell proliferation, polyamine biosynthesis, and polyamine transport.
Gawel-Thompson KJ; Greene RM
J Cell Physiol; 1989 Aug; 140(2):359-70. PubMed ID: 2501317
[TBL] [Abstract][Full Text] [Related]
22. Cytotoxic response of the relatively difluoromethylornithine-resistant human lung tumor cell line NCI H157 to the polyamine analogue N1,N8-bis(ethyl)spermidine.
Casero RA; Go B; Theiss HW; Smith J; Baylin SB; Luk GD
Cancer Res; 1987 Aug; 47(15):3964-7. PubMed ID: 3038303
[TBL] [Abstract][Full Text] [Related]
23. Polyamine-iron chelator conjugate.
Bergeron RJ; McManis JS; Franklin AM; Yao H; Weimar WR
J Med Chem; 2003 Dec; 46(25):5478-83. PubMed ID: 14640556
[TBL] [Abstract][Full Text] [Related]
24. Spermine oxidase SMO(PAOh1), Not N1-acetylpolyamine oxidase PAO, is the primary source of cytotoxic H2O2 in polyamine analogue-treated human breast cancer cell lines.
Pledgie A; Huang Y; Hacker A; Zhang Z; Woster PM; Davidson NE; Casero RA
J Biol Chem; 2005 Dec; 280(48):39843-51. PubMed ID: 16207710
[TBL] [Abstract][Full Text] [Related]
25. Concurrent overexpression of ornithine decarboxylase and spermidine/spermine N(1)-acetyltransferase further accelerates the catabolism of hepatic polyamines in transgenic mice.
Suppola S; Heikkinen S; Parkkinen JJ; Uusi-Oukari M; Korhonen VP; Keinänen T; Alhonen L; Jänne J
Biochem J; 2001 Sep; 358(Pt 2):343-8. PubMed ID: 11513732
[TBL] [Abstract][Full Text] [Related]
26. Revival of 2-(difluoromethyl)ornithine (DFMO), an inhibitor of polyamine biosynthesis, as a cancer chemopreventive agent.
Raul F
Biochem Soc Trans; 2007 Apr; 35(Pt 2):353-5. PubMed ID: 17371277
[TBL] [Abstract][Full Text] [Related]
27. 2,2'-Dithiobis(N-ethyl-spermine-5-carboxamide) is a high affinity, membrane-impermeant antagonist of the mammalian polyamine transport system.
Huber M; Pelletier JG; Torossian K; Dionne P; Gamache I; Charest-Gaudreault R; Audette M; Poulin R
J Biol Chem; 1996 Nov; 271(44):27556-63. PubMed ID: 8910341
[TBL] [Abstract][Full Text] [Related]
28. Potentiation of naphthoxyloside cytotoxicity on human tumor cells by difluoromethylornithine and spermine-NONOate.
Cheng F; Johnsson R; Nilsson J; Fransson LA; Ellervik U; Mani K
Cancer Lett; 2009 Jan; 273(1):148-54. PubMed ID: 18783879
[TBL] [Abstract][Full Text] [Related]
29. Individual and combined effects of alpha-difluoromethylornithine and ovariectomy on the growth and polyamine milieu of experimental breast cancer in rats.
Manni A; Badger B; Glikman P; Bartholomew M; Santner S; Demers L
Cancer Res; 1989 Jul; 49(13):3529-34. PubMed ID: 2499419
[TBL] [Abstract][Full Text] [Related]
30. The gastrointestinal polyamine source depletion enhances DFMO induced polyamine depletion in MCF-7 human breast cancer cells in vivo.
Levêque J; Burtin F; Catros-Quemener V; Havouis R; Moulinoux JP
Anticancer Res; 1998; 18(4A):2663-8. PubMed ID: 9703925
[TBL] [Abstract][Full Text] [Related]
31. The polyamine analogue N1,N11-diethylnorspermine can induce chondrocyte apoptosis independently of its ability to alter metabolism and levels of natural polyamines.
Stanic' I; Facchini A; Borzì RM; Stefanelli C; Flamigni F
J Cell Physiol; 2009 Apr; 219(1):109-16. PubMed ID: 19097065
[TBL] [Abstract][Full Text] [Related]
32. Polyamines as targets for therapeutic intervention.
Marton LJ; Pegg AE
Annu Rev Pharmacol Toxicol; 1995; 35():55-91. PubMed ID: 7598507
[TBL] [Abstract][Full Text] [Related]
33. Sensitization of tnf-induced apoptosis with polyamine synthesis inhibitors in different human and murine tumour cell lines.
Penning LC; Schipper RG; Vercammen D; Verhofstad AA; Denecker T; Beyaert R; Vandenabeele P
Cytokine; 1998 Jun; 10(6):423-31. PubMed ID: 9632528
[TBL] [Abstract][Full Text] [Related]
34. Relative abilities of bis(ethyl) derivatives of putrescine, spermidine, and spermine to regulate polyamine biosynthesis and inhibit L1210 leukemia cell growth.
Porter CW; McManis J; Casero RA; Bergeron RJ
Cancer Res; 1987 Jun; 47(11):2821-5. PubMed ID: 3567905
[TBL] [Abstract][Full Text] [Related]
35. Polyamine Antagonist Therapies Inhibit Neuroblastoma Initiation and Progression.
Evageliou NF; Haber M; Vu A; Laetsch TW; Murray J; Gamble LD; Cheng NC; Liu K; Reese M; Corrigan KA; Ziegler DS; Webber H; Hayes CS; Pawel B; Marshall GM; Zhao H; Gilmour SK; Norris MD; Hogarty MD
Clin Cancer Res; 2016 Sep; 22(17):4391-404. PubMed ID: 27012811
[TBL] [Abstract][Full Text] [Related]
36. Collateral sensitivity of human melanoma multidrug-resistant variants to the polyamine analogue, N1,N11-diethylnorspermine.
Porter CW; Ganis B; Rustum Y; Wrzosek C; Kramer DL; Bergeron RJ
Cancer Res; 1994 Nov; 54(22):5917-24. PubMed ID: 7954423
[TBL] [Abstract][Full Text] [Related]
37. Hypoxia-mediated induction of the polyamine system provides opportunities for tumor growth inhibition by combined targeting of vascular endothelial growth factor and ornithine decarboxylase.
Svensson KJ; Welch JE; Kucharzewska P; Bengtson P; Bjurberg M; Påhlman S; Ten Dam GB; Persson L; Belting M
Cancer Res; 2008 Nov; 68(22):9291-301. PubMed ID: 19010902
[TBL] [Abstract][Full Text] [Related]
38. CGP 48664, a new S-adenosylmethionine decarboxylase inhibitor with broad spectrum antiproliferative and antitumor activity.
Regenass U; Mett H; Stanek J; Mueller M; Kramer D; Porter CW
Cancer Res; 1994 Jun; 54(12):3210-7. PubMed ID: 8205541
[TBL] [Abstract][Full Text] [Related]
39. Polyamine synthesis and transport inhibition in a human anaplastic thyroid carcinoma cell line in vitro and as xenograft tumors.
Yatin M; Venkataraman GM; Marcinek R; Ain KB
Thyroid; 1999 Aug; 9(8):805-14. PubMed ID: 10482374
[TBL] [Abstract][Full Text] [Related]
40. Epidermal keratinocytes actively maintain their intracellular polyamine levels.
Roseeuw DI; Marcelo CL; Rhodes LM; Voorhees JJ
Cell Tissue Kinet; 1983 Sep; 16(5):493-504. PubMed ID: 6192925
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
